| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4.30B | — | +17.4% |
| Cost of Revenue | $2.47B | — | +26.1% |
| Gross Profit | $1.84B | — | +7.5% |
| R&D Expense | $259.0M | — | +20.5% |
| SG&A Expense | $533.0M | — | +23.7% |
| Operating Income | $79.0M | — | -64.6% |
| Interest Expense | $164.0M | — | +59.2% |
| Pre-tax Income | $234.0M | — | -33.9% |
| Income Tax | $25.0M | — | +31.6% |
| Net Income | $209.0M | — | -37.6% |
| EPS (Basic) | $1.24 | — | -22.0% |
| EPS (Diluted) | $1.23 | — | -21.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.51B | -17.3% | -1.6% |
| Accounts Receivable | $155.0M | -18.4% | +42.2% |
| Current Assets | $4.50B | -6.2% | +6.1% |
| Total Assets | $28.47B | -2.8% | +14.7% |
| Current Liabilities | $4.98B | -1.2% | +11.4% |
| Long-term Debt | $11.96B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $330.0M | — | +75.5% |
| Capital Expenditures | $25.0M | — | +31.6% |
| Investing Cash Flow | -$172.0M | — | -72.0% |
| Financing Cash Flow | -$458.0M | — | -69.0% |
| Free Cash Flow | $305.0M | — | +80.5% |
| +75.3% |
| Total Liabilities | $18.77B | -4.2% | +43.8% |
| Stockholders' Equity | $9.06B | +0.3% | -8.1% |